An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer.

We propose that the D-D1 peptide from IL13Rα2 represents a promising therapeutic agent to inhibit metastatic progression in colorectal cancer and, likely, other solid tumours.